Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion

ACS Chemical Neuroscience

Volumn 6, Issue 9, 2015, Pages 1517-1525

  Pignataro, Giuseppe ^a   Ziaco, Barbara ^c   Tortiglione, Anna ^a   Gala, Rosaria ^a   Cuomo, Ornella ^a   Vinciguerra, Antonio ^a   Lapi, Dominga ^b   Mastantuono, Teresa ^b   Anzilotti, Serenella ^d   D'Andrea, Luca Domenico ^c   Pedone, Carlo ^c   Di Renzo, Gianfranco ^a   Annunziato, Lucio ^a,d   Cataldi, Mauro ^a  

^a Division of Pharmacology Department of Neuroscience Reproductive and Odontostomatologic Sciences   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CNR   (Italy)

^d IRCCS SDN   (Italy)

Author keywords

brain edema; Cerebral ischemia; neuroprotection; vascular endothelial growth factor; vascular permeability

Indexed keywords

DEXTRAN; ERYTHROPOIETIN; FLUORESCEIN; NERVE GROWTH FACTOR; PEPTIDE; PEPTIDE QK; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; NEUROPROTECTIVE AGENT; QK VEGF MIMETIC PEPTIDE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN EDEMA; BRAIN ISCHEMIA; CONTROLLED STUDY; HEMISPHERE; MALE; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; CAPILLARY PERMEABILITY; CEREBRAL ARTERY DISEASE; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; STROKE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; PEPTIDES; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84942052724     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.5b00175     Document Type: Article

References (64)

1. Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., and Carmeliet, P. (2009) Role and therapeutic potential of VEGF in the nervous system Physiol. Rev. 89, 607-648 10.1152/physrev.00031.2008
2. Marti, H. J., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E., and Risau, W. (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia Am. J. Pathol. 156, 965-976 10.1016/S0002-9440(10)64964-4
3. Beck, H. and Plate, K. H. (2009) Angiogenesis after cerebral ischemia Acta Neuropathol. 117, 481-496 10.1007/s00401-009-0483-6
4. Liman, T. G. and Endres, M. (2012) New vessels after stroke: postischemic neovascularization and regeneration Cerebrovasc. Dis. 33, 492-499 10.1159/000337155
5. Schmidt, N. O., Koeder, D., Messing, M., Mueller, F. J., Aboody, K. S., Kim, S. U., Black, P. M., Carroll, R. S., Westphal, M., and Lamszus, K. (2009) Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche Brain Res. 1268, 24-37 10.1016/j.brainres.2009.02.065
6. Li, Q., Ford, M. C., Lavik, E. B., and Madri, J. A. (2006) Modeling the neurovascular niche: VEGF- and BDNF-mediated cross-talk between neural stem cells and endothelial cells: an in vitro study J. Neurosci. Res. 84, 1656-1668 10.1002/jnr.21087
7. Ma, Y., Zechariah, A., Qu, Y., and Hermann, D. M. (2012) Effects of vascular endothelial growth factor in ischemic stroke J. Neurosci. Res. 90, 1873-1882 10.1002/jnr.23088
8. Jin, K. L., Mao, X. O., and Greenberg, D. A. (2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia Proc. Natl. Acad. Sci. U. S. A. 97, 10242-1027 10.1073/pnas.97.18.10242
9. Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M. P., Mitsuda, N., and Tohyama, M. (2001) Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades FASEB J. 15, 1218-1220 10.1096/fj.00-0495fje
10. Svensson, B., Peters, M., Konig, H. G., Poppe, M., Levkau, B., Rothermundt, M., Arolt, V., Kögel, D., and Prehn, J. H. (2002) Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism J. Cereb. Blood Flow Metab. 22, 1170-1175 10.1097/00004647-200210000-00003
11. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., and Greenberg, D. A. (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia J. Clin. Invest. 111, 1843-1851 10.1172/JCI200317977
12. Cataldi, M. (2013) The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases Curr. Neuropharmacol. 11, 276-297 10.2174/1570159X11311030004
13. Annunziato, L., Pignataro, G., Boscia, F., Sirabella, R., Formisano, L., Saggese, M., Cuomo, O., Gala, R., Secondo, A., Viggiano, D., Molinaro, P., Valsecchi, V., Tortiglione, A., Adornetto, A., Scorziello, A., Cataldi, M., and Di Renzo, G. F. (2007) ncx1, ncx2, and ncx3 gene product expression and function in neuronal anoxia and brain ischemia Ann. N. Y. Acad. Sci. 1099, 413-426 10.1196/annals.1387.050
14. Annunziato, L., Cataldi, M., Pignataro, G., Secondo, A., and Molinaro, P. (2007) Glutamate-independent calcium toxicity: introduction Stroke 38 (2 Suppl) 661-664 10.1161/01.STR.0000247942.42349.37
15. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219, 983-985 10.1126/science.6823562
16. Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, Nv, and Chopp, M. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain J. Clin. Invest. 106, 829-838 10.1172/JCI9369
17. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. (2000) Vascular-specific growth factors and blood vessel formation Nature 407, 242-248 10.1038/35025215
18. Bates, D. O. and Curry, F. E. (1996) Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels Am. J. Physiol. 271, 2520-2528
19. Dobrogowska, D. H., Lossinsky, A. S., Tarnawski, M., and Vorbrodt, A. W. (1998) Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor J. Neurocytol. 27, 163-173 10.1023/A:1006907608230
20. Roberts, W. G. and Palade, G. E. (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor J. Cell. Sci. 108, 2369-2379
21. Weis, S. M. and Cheresh, D. A. (2005) Pathophysiological consequences of VEGF-induced vascular permeability Nature 437, 497-504 10.1038/nature03987
22. Ngok, S. P., Geyer, R., Liu, M., Kourtidis, A., Agrawal, S., Wu, C., Seerapu, H. R., Lewis-Tuffin, L. J., Moodie, K. L., Huveldt, D., Marx, R., Baraban, J. M., Storz, P., Horowitz, A., and Anastasiadis, P. Z. (2012) VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx J. Cell Biol. 199, 1103-1115 10.1083/jcb.201207009
23. Schoch, H. J., Fischer, S., and Marti, H. H. (2002) Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain Brain 125 (Pt 11) 2549-2557 10.1093/brain/awf257
24. van Bruggen, N., Thibodeaux, H., Palmer, J. T., Lee, W. P., Fu, L., Cairns, B., Tumas, D., Gerlai, R., Williams, S. P., van Lookeren Campagne, M., and Ferrara, N. (1999) VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain J. Clin. Invest. 104, 1613-1620 10.1172/JCI8218
25. D'Andrea, L. D., Del Gatto, A., De Rosa, L., Romanelli, A., and Pedone, C. (2009) Peptides targeting angiogenesis related growth factor receptors Curr. Pharm. Des. 15, 2414-2429 10.2174/138161209788682235
26. Diana, D., Basile, A., De Rosa, L., Di Stasi, R., Auriemma, S., Arra, C., Pedone, C., Turco, M. C., Fattorusso, R., and D'Andrea, L. D. (2011) β-hairpin peptide that targets vascular endothelial growth factor (VEGF) receptors: design, NMR characterization, and biological activity J. Biol. Chem. 286, 41680-41691 10.1074/jbc.M111.257402
27. D'Andrea, L. D., Iaccarino, G., Fattorusso, R., Sorriento, D., Carannante, C., Capasso, D., Trimarco, B., and Pedone, C. (2005) Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide Proc. Natl. Acad. Sci. U. S. A. 102, 14215-14220 10.1073/pnas.0505047102
28. Diana, D., Ziaco, B., Colombo, G., Scarabelli, G., Romanelli, A., Pedone, C., Fattorusso, R., and D'Andrea, L. D. (2008) Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide Chem.-Eur. J. 14, 4164-4166 10.1002/chem.200800180
29. Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C., and Wells, J. A. et al. 1997, Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor Cell 91, 695-704 10.1016/S0092-8674(00)80456-0
30. Finetti, F., Basile, A., Capasso, D., Di Gaetano, S., Di Stasi, R., Pascale, M., Turco, C. M., Ziche, M., Morbidelli, L., and D'Andrea, L. D. (2012) Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis Biochem. Pharmacol. 84, 303-311 10.1016/j.bcp.2012.04.011
31. Dudar, G. K., D'Andrea, L. D., Di Stasi, R., Pedone, C., and Wallace, J. L. (2008) A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner Am. J. Physiol. Gastrointest. Liver Physiol. 295, G374-81 10.1152/ajpgi.90325.2008
32. Santulli, G., Ciccarelli, M., Palumbo, G., Campanile, A., Galasso, G., Ziaco, B., Altobelli, G. G., Cimini, V., Piscione, F., D'Andrea, L. D., Pedone, C., Trimarco, B., and Iaccarino, G. (2009) In vivo properties of the proangiogenic peptide QK J. Transl. Med. 7, 41 10.1186/1479-5876-7-41
33. Verheyen, A., Peeraer, E., Lambrechts, D., Poesen, K., Carmeliet, P., Shibuya, M., Pintelon, I., Timmermans, J. P., Nuydens, R., and Meert, T. (2013) Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies Neuroscience 244, 77-89 10.1016/j.neuroscience.2013.03.050
34. Misra, A. and Kher, G. (2012) Drug delivery systems from nose to brain Curr. Pharm. Biotechnol. 13, 2355-2379 10.2174/138920112803341752
35. Thorne, R. G. and Frey, W. H., II (2001) Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations Clin. Pharmacokinet. 40, 907-946 10.2165/00003088-200140120-00003
36. Gomez, D., Martinez, J. A., Hanson, L. R., Frey, W. H., 2nd, and Toth, C. C. (2012) Intranasal treatment of neurodegenerative diseases and stroke Front. Biosci., Scholar Ed. 4, 74-89 10.2741/252
37. Chapman, C. D., Frey, W. H., 2nd, Craft, S., Danielyan, L., Hallschmid, M., Schiöth, and Benedict, C. (2013) Intranasal treatment of central nervous system dysfunction in humans Pharm. Res. 30, 2475-2484 10.1007/s11095-012-0915-1
38. Liu, X. F., Fawcett, J. R., Thorne, R. G., and Frey, W. H., II (2001) Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion Neurosci. Lett. 308, 91-94 10.1016/S0304-3940(01)01982-6
39. Rodríguez Cruz, Y., Mengana Támos, Y., Muñoz Cernuda, A., Subirós Martines, N., González-Quevedo, A., Sosa Testé, I., and García Rodríguez, J. C. (2010) Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia Sci. World J. 10, 2288-300 10.1100/tsw.2010.215
40. Zhao, H. M., Liu, X. F., Mao, X. W., and Chen, C. F. (2004) Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction Chin. Med. Sci. J. 19, 257-61
41. Ma, M., Ma, Y., Yi, X., Guo, R., Zhu, W., Fan, X., Xu, G., Frey, W. H., 2nd, and Liu, X. (2008) Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone BMC Neurosci. 9, 117 10.1186/1471-2202-9-117
42. Yang, J. P., Liu, H. J., Wang, Z. L., Cheng, S. M., and Cheng, X. et al. 2009, The dose-effectiveness of intranasal VEGF in treatment of experimental stroke Neurosci. Lett. 461, 212-6 10.1016/j.neulet.2009.06.060
43. Yang, J. P., Liu, H. J., Cheng, S. M., Wang, Z. L., Cheng, X., Yu, H. X., and Liu, X. F. (2009) Direct transport of VEGF from the nasal cavity to brain Neurosci. Lett. 449, 108-111 10.1016/j.neulet.2008.10.090
44. Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Buadze, M., Geisler, J., Klopfer, T., Burkhardt, U., Proksch, B., Verleysdonk, S., Ayturan, M., Buniatian, G. H., Gleiter, C. H., and Frey, W. H., 2nd (2009) Intranasal delivery of cells to the brain Eur. J. Cell Biol. 88, 315-324 10.1016/j.ejcb.2009.02.001
45. Carmichael, S. T. (2005) Rodent models of focal stroke: size, mechanism, and purpose NeuroRx 2, 396-409 10.1602/neurorx.2.3.396
46. Lou, M., Blume, A., Zhao, Y., Gohlke, P., Deuschl, G., Herdegen, T., and Culman, J. (2004) Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat J. Cereb. Blood Flow Metab. 24, 536-47 10.1097/00004647-200405000-00008
47. Manoonkitiwongsa, P. S., Schultz, R. L., McCreery, D. B., Whitter, E. F., and Lyden, P. D. (2004) Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis J. Cereb. Blood Flow Metab. 24, 693-702 10.1097/01.WCB.0000126236.54306.21
48. Kiba, A., Sagara, H., Hara, T., and Shibuya, M. (2003) VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice Biochem. Biophys. Res. Commun. 301, 371-377 10.1016/S0006-291X(02)03033-4
49. Vogel, C., Bauer, A., Wiesnet, M., Preissner, K. T., Schaper, W., Marti, H. H., and Fischer, S. (2007) Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway J. Cell. Physiol. 212, 236-243 10.1002/jcp.21022
50. Olsson, A. K., Dimberg, A., Kreuger, J., and Claesson-Welsh, L. (2006) VEGF receptor signalling-in control of vascular function Nat. Rev. Mol. Cell Biol. 7, 359-371 10.1038/nrm1911
51. Suarez, S. and Ballmer-Hofer, K. (2001) VEGF transiently disrupts gap junctional communication in endothelial cells J. Cell. Sci. 114, 1229-1235
52. Weis, S. M. and Cheresh, D. A. (2005) Pathophysiological consequences of VEGF-induced vascular permeability Nature 437, 497-504 10.1038/nature03987
53. Eriksson, A., Cao, R., Roy, J., Tritsaris, K., Wahlestedt, C., Dissing, S., Thyberg, J., and Cao, Y. (2003) Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability Circulation 107, 1532-1538 10.1161/01.CIR.0000055324.34758.32
54. Lal, B. K., Varma, S., Pappas, P. J., Hobson, R. W., 2nd, and Durán, W. N. (2001) VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways Microvasc. Res. 62, 252-262 10.1006/mvre.2001.2338
55. Spyridopoulos, I., Luedemann, C., Chen, D., Kearney, M., Chen, D., Murohara, T., Principe, N., Isner, J. M., and Losordo, D. W. (2002) Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability Arterioscler., Thromb., Vasc. Biol. 22, 901-906 10.1161/01.ATV.0000020006.89055.11
56. Zhang, Y., Furumura, M., and Morita, E. (2008) Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165 Growth Factors 26, 125-131 10.1080/08977190802105909
57. Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., and Ferrara, N. (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis J. Biol. Chem. 271, 5638-5646 10.1074/jbc.271.10.5638
58. Tortiglione, A., Minale, M., Pignataro, G., Amoroso, S., Di Renzo, G., and Annunziato, L. (2002) The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats Neuropharmacology 43, 427-433 10.1016/S0028-3908(02)00093-X
59. Pignataro, G., Gala, R., Cuomo, O., Tortiglione, A., Giaccio, L., Castaldo, P., Sirabella, R., Matrone, C., Canitano, A., Amoroso, S., Di Renzo, G., and Annunziato, L. (2004) Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia Stroke 35, 2566-2570 10.1161/01.STR.0000143730.29964.93
60. Clark, W. M., Lessov, N. S., Dixon, M. P., and Eckenstein, F. (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse Neurol. Res. 19, 641-648
61. Cuomo, O., Rispoli, V., Leo, A., Politi, G. B., Vinciguerra, A., di Renzo, G., and Cataldi, M. (2013) The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion PLoS One 8, e80852 10.1371/journal.pone.0080852
62. Boscia, F., Gala, R., Pannaccione, A., Secondo, A., Scorziello, A., Di Renzo, G., and Annunziato, L. (2009) NCX1 expression and functional activity increase in microglia invading the infarct core Stroke 40, 3608-3617 10.1161/STROKEAHA.109.557439
63. Lapi, D., Vagnani, S., Pignataro, G., Esposito, E., Paterni, M., and Colantuoni, A. (2012) Rat Pial Microvascular Responses to Transient Bilateral Common Carotid Artery Occlusion and Reperfusion: Quercetin's Mechanism of Action Front. Physiol. 3, 99 10.3389/fphys.2012.00099
64. Mayhan, W. G. (2002) Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier Brain Res. 927, 144-52 10.1016/S0006-8993(01)03348-0